Home › Migraine › Illinois › Naperville
Migraine clinical trials in Naperville, IL
4 studies for Migraine are looking for participants at sites in and around Naperville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
RecruitingPhase 3
- AMR-Baber Research Inc, Naperville
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
RecruitingPhase 3
- AMR-Baber Research Inc, Naperville
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
RecruitingPhase 3
- Chicago Headache Center & Research Institute, Naperville
Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
RecruitingObservational study
- Chicago Headache Center & Research Inst /ID# 272345, Naperville
About Migraine
Migraines are pulsing or throbbing headaches in one area of the head. Learn about other symptoms, what triggers migraines, and how to treat them.
More about Migraine on MedlinePlus
Migraine trials in other cities
- Cincinnati, OH11 studies
- Austin, TX8 studies
- Miami, FL8 studies
- Philadelphia, PA8 studies
- Concord, CA8 studies
- Amherst, NY7 studies
- Omaha, NE7 studies
- Houston, TX7 studies
- Washington, DC7 studies
- Aurora, CO6 studies
- Stamford, CT6 studies
- San Diego, CA6 studies
Other studies in Naperville
- Non-Small Cell Lung Cancer16 studies
- Lung Cancer13 studies
- Heart Failure13 studies
- Prostate Cancer10 studies
- Breast Cancer9 studies
- Cardiovascular Disease8 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Geographic Atrophy6 studies
- Macular Degeneration6 studies
- Pancreatic Cancer6 studies
- Cancer (all types)5 studies
- Atrial Fibrillation5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.